1 Study Coverage 1.1 PD-L1 Biomarker Testing Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million) Introduction 1.2 Global PD-L1 Biomarker Testing Outlook 2017 VS 2022 VS 2028 1.2.1 Global PD-L1 Biomarker Testing Market Size for the Year 2017-2028 1.2.2 Global PD-L1 Biomarker Testing Market Size for the Year 2017-2028 1.3 PD-L1 Biomarker Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States PD-L1 Biomarker Testing in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of PD-L1 Biomarker Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 PD-L1 Biomarker Testing Market Dynamics 1.4.1 PD-L1 Biomarker Testing Industry Trends 1.4.2 PD-L1 Biomarker Testing Market Drivers 1.4.3 PD-L1 Biomarker Testing Market Challenges 1.4.4 PD-L1 Biomarker Testing Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 PD-L1 Biomarker Testing by Type 2.1 PD-L1 Biomarker Testing Market Segment by Type 2.1.1 PD-L1 (22C3) 2.1.2 PD-L1(28-8) 2.1.3 PD-L1 (SP142) 2.1.4 PD-L1 (SP263) 2.1.5 Other 2.2 Global PD-L1 Biomarker Testing Market Size by Type (2017, 2022 & 2028) 2.3 Global PD-L1 Biomarker Testing Market Size by Type (2017-2028) 2.4 United States PD-L1 Biomarker Testing Market Size by Type (2017, 2022 & 2028) 2.5 United States PD-L1 Biomarker Testing Market Size by Type (2017-2028) 3 PD-L1 Biomarker Testing by Application 3.1 PD-L1 Biomarker Testing Market Segment by Application 3.1.1 Hospital 3.1.2 Diagnostic Center 3.1.3 Others 3.2 Global PD-L1 Biomarker Testing Market Size by Application (2017, 2022 & 2028) 3.3 Global PD-L1 Biomarker Testing Market Size by Application (2017-2028) 3.4 United States PD-L1 Biomarker Testing Market Size by Application (2017, 2022 & 2028) 3.5 United States PD-L1 Biomarker Testing Market Size by Application (2017-2028) 4 Global PD-L1 Biomarker Testing Competitor Landscape by Company 4.1 Global PD-L1 Biomarker Testing Market Size by Company 4.1.1 Top Global PD-L1 Biomarker Testing Companies Ranked by Revenue (2021) 4.1.2 Global PD-L1 Biomarker Testing Revenue by Player (2017-2022) 4.2 Global PD-L1 Biomarker Testing Concentration Ratio (CR) 4.2.1 PD-L1 Biomarker Testing Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of PD-L1 Biomarker Testing in 2021 4.2.3 Global PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global PD-L1 Biomarker Testing Headquarters, Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million) Type 4.3.1 Global PD-L1 Biomarker Testing Headquarters and Area Served 4.3.2 Global PD-L1 Biomarker Testing Companies Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into PD-L1 Biomarker Testing Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States PD-L1 Biomarker Testing Market Size by Company 4.5.1 Top PD-L1 Biomarker Testing Players in United States, Ranked by Revenue (2021) 4.5.2 United States PD-L1 Biomarker Testing Revenue by Players (2020, 2021 & 2022) 5 Global PD-L1 Biomarker Testing Market Size by Region 5.1 Global PD-L1 Biomarker Testing Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global PD-L1 Biomarker Testing Market Size by Region (2017-2028) 5.2.1 Global PD-L1 Biomarker Testing Market Size by Region: 2017-2022 5.2.2 Global PD-L1 Biomarker Testing Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America PD-L1 Biomarker Testing Market Size YoY Growth 2017-2028 6.1.2 North America PD-L1 Biomarker Testing Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific PD-L1 Biomarker Testing Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific PD-L1 Biomarker Testing Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe PD-L1 Biomarker Testing Market Size YoY Growth 2017-2028 6.3.2 Europe PD-L1 Biomarker Testing Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America PD-L1 Biomarker Testing Market Size YoY Growth 2017-2028 6.4.2 Latin America PD-L1 Biomarker Testing Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa PD-L1 Biomarker Testing Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa PD-L1 Biomarker Testing Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 Agilent Technologies 7.1.1 Agilent Technologies Company Details 7.1.2 Agilent Technologies Business Overview 7.1.3 Agilent Technologies PD-L1 Biomarker Testing Introduction 7.1.4 Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2017-2022) 7.1.5 Agilent Technologies Recent Development 7.2 Roche 7.2.1 Roche Company Details 7.2.2 Roche Business Overview 7.2.3 Roche PD-L1 Biomarker Testing Introduction 7.2.4 Roche Revenue in PD-L1 Biomarker Testing Business (2017-2022) 7.2.5 Roche Recent Development 7.3 Merck 7.3.1 Merck Company Details 7.3.2 Merck Business Overview 7.3.3 Merck PD-L1 Biomarker Testing Introduction 7.3.4 Merck Revenue in PD-L1 Biomarker Testing Business (2017-2022) 7.3.5 Merck Recent Development 7.4 Bristol-Myers Squibb 7.4.1 Bristol-Myers Squibb Company Details 7.4.2 Bristol-Myers Squibb Business Overview 7.4.3 Bristol-Myers Squibb PD-L1 Biomarker Testing Introduction 7.4.4 Bristol-Myers Squibb Revenue in PD-L1 Biomarker Testing Business (2017-2022) 7.4.5 Bristol-Myers Squibb Recent Development 7.5 AstraZeneca 7.5.1 AstraZeneca Company Details 7.5.2 AstraZeneca Business Overview 7.5.3 AstraZeneca PD-L1 Biomarker Testing Introduction 7.5.4 AstraZeneca Revenue in PD-L1 Biomarker Testing Business (2017-2022) 7.5.5 AstraZeneca Recent Development 7.6 Ono Pharmaceutical 7.6.1 Ono Pharmaceutical Company Details 7.6.2 Ono Pharmaceutical Business Overview 7.6.3 Ono Pharmaceutical PD-L1 Biomarker Testing Introduction 7.6.4 Ono Pharmaceutical Revenue in PD-L1 Biomarker Testing Business (2017-2022) 7.6.5 Ono Pharmaceutical Recent Development 7.7 Regeneron 7.7.1 Regeneron Company Details 7.7.2 Regeneron Business Overview 7.7.3 Regeneron PD-L1 Biomarker Testing Introduction 7.7.4 Regeneron Revenue in PD-L1 Biomarker Testing Business (2017-2022) 7.7.5 Regeneron Recent Development 7.8 Innovent 7.8.1 Innovent Company Details 7.8.2 Innovent Business Overview 7.8.3 Innovent PD-L1 Biomarker Testing Introduction 7.8.4 Innovent Revenue in PD-L1 Biomarker Testing Business (2017-2022) 7.8.5 Innovent Recent Development 7.9 Hengrui Medicine 7.9.1 Hengrui Medicine Company Details 7.9.2 Hengrui Medicine Business Overview 7.9.3 Hengrui Medicine PD-L1 Biomarker Testing Introduction 7.9.4 Hengrui Medicine Revenue in PD-L1 Biomarker Testing Business (2017-2022) 7.9.5 Hengrui Medicine Recent Development 7.10 Junshi Biosciences 7.10.1 Junshi Biosciences Company Details 7.10.2 Junshi Biosciences Business Overview 7.10.3 Junshi Biosciences PD-L1 Biomarker Testing Introduction 7.10.4 Junshi Biosciences Revenue in PD-L1 Biomarker Testing Business (2017-2022) 7.10.5 Junshi Biosciences Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. PD-L1 Biomarker Testing Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. PD-L1 Biomarker Testing Market Trends Table 3. PD-L1 Biomarker Testing Market Drivers Table 4. PD-L1 Biomarker Testing Market Challenges Table 5. PD-L1 Biomarker Testing Market Restraints Table 6. Global PD-L1 Biomarker Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States PD-L1 Biomarker Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global PD-L1 Biomarker Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States PD-L1 Biomarker Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top PD-L1 Biomarker Testing Companies in Global Market, Ranking by Revenue (2021) Table 11. Global PD-L1 Biomarker Testing Revenue by Player, (US$ Million), 2017-2022 Table 12. Global PD-L1 Biomarker Testing Revenue Share by Player, 2017-2022 Table 13. Global PD-L1 Biomarker Testing Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global PD-L1 Biomarker Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing as of 2021) Table 15. Top Players of PD-L1 Biomarker Testing in Global Market, Headquarters and Area Served Table 16. Companies Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into PD-L1 Biomarker Testing Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top PD-L1 Biomarker Testing Players in United States Market, Ranking by Revenue (2021) Table 20. United States PD-L1 Biomarker Testing Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States PD-L1 Biomarker Testing Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global PD-L1 Biomarker Testing Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global PD-L1 Biomarker Testing Market Size by Region (2017-2022) & (US$ Million) Table 24. Global PD-L1 Biomarker Testing Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America PD-L1 Biomarker Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific PD-L1 Biomarker Testing Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe PD-L1 Biomarker Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa PD-L1 Biomarker Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa PD-L1 Biomarker Testing Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Agilent Technologies Company Details Table 31. Agilent Technologies Business Overview Table 32. Agilent Technologies PD-L1 Biomarker Testing Product Table 33. Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million) Table 34. Agilent Technologies Recent Development Table 35. Roche Company Details Table 36. Roche Business Overview Table 37. Roche PD-L1 Biomarker Testing Product Table 38. Roche Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million) Table 39. Roche Recent Development Table 40. Merck Company Details Table 41. Merck Business Overview Table 42. Merck PD-L1 Biomarker Testing Product Table 43. Merck Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million) Table 44. Merck Recent Development Table 45. Bristol-Myers Squibb Company Details Table 46. Bristol-Myers Squibb Business Overview Table 47. Bristol-Myers Squibb PD-L1 Biomarker Testing Product Table 48. Bristol-Myers Squibb Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million) Table 49. Bristol-Myers Squibb Recent Development Table 50. AstraZeneca Company Details Table 51. AstraZeneca Business Overview Table 52. AstraZeneca PD-L1 Biomarker Testing Product Table 53. AstraZeneca Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million) Table 54. AstraZeneca Recent Development Table 55. Ono Pharmaceutical Company Details Table 56. Ono Pharmaceutical Business Overview Table 57. Ono Pharmaceutical PD-L1 Biomarker Testing Product Table 58. Ono Pharmaceutical Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million) Table 59. Ono Pharmaceutical Recent Development Table 60. Regeneron Company Details Table 61. Regeneron Business Overview Table 62. Regeneron PD-L1 Biomarker Testing Product Table 63. Regeneron Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million) Table 64. Regeneron Recent Development Table 65. Innovent Company Details Table 66. Innovent Business Overview Table 67. Innovent PD-L1 Biomarker Testing Product Table 68. Innovent Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million) Table 69. Innovent Recent Development Table 70. Hengrui Medicine Company Details Table 71. Hengrui Medicine Business Overview Table 72. Hengrui Medicine PD-L1 Biomarker Testing Product Table 73. Hengrui Medicine Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million) Table 74. Hengrui Medicine Recent Development Table 75. Junshi Biosciences Company Details Table 76. Junshi Biosciences Business Overview Table 77. Junshi Biosciences PD-L1 Biomarker Testing Product Table 78. Junshi Biosciences Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million) Table 79. Junshi Biosciences Recent Development Table 80. Research Programs/Design for This Report Table 81. Key Data Information from Secondary Sources Table 82. Key Data Information from Primary Sources List of Figures Figure 1. PD-L1 Biomarker Testing Product Picture Figure 2. Global PD-L1 Biomarker Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global PD-L1 Biomarker Testing Market Size 2017-2028 (US$ Million) Figure 4. United States PD-L1 Biomarker Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States PD-L1 Biomarker Testing Market Size 2017-2028 (US$ Million) Figure 6. United States PD-L1 Biomarker Testing Market Share in Global 2017-2028 Figure 7. PD-L1 Biomarker Testing Report Years Considered Figure 8. Product Picture of PD-L1 (22C3) Figure 9. Product Picture of PD-L1(28-8) Figure 10. Product Picture of PD-L1 (SP142) Figure 11. Product Picture of PD-L1 (SP263) Figure 12. Product Picture of Other Figure 13. Global PD-L1 Biomarker Testing Market Share by Type in 2022 & 2028 Figure 14. Global PD-L1 Biomarker Testing Market Size by Type (2017-2028) & (US$ Million) Figure 15. Global PD-L1 Biomarker Testing Market Share by Type (2017-2028) Figure 16. United States PD-L1 Biomarker Testing Market Share by Type in 2022 & 2028 Figure 17. United States PD-L1 Biomarker Testing Market Size by Type (2017-2028) & (US$ Million) Figure 18. United States PD-L1 Biomarker Testing Market Share by Type (2017-2028) Figure 19. Product Picture of Hospital Figure 20. Product Picture of Diagnostic Center Figure 21. Product Picture of Others Figure 22. Global PD-L1 Biomarker Testing Market Share by Application in 2022 & 2028 Figure 23. Global PD-L1 Biomarker Testing Market Size by Application (2017-2028) & (US$ Million) Figure 24. Global PD-L1 Biomarker Testing Market Share by Application (2017-2028) Figure 25. United States PD-L1 Biomarker Testing Market Share by Application in 2022 & 2028 Figure 26. United States PD-L1 Biomarker Testing Market Size by Application (2017-2028) & (US$ Million) Figure 27. United States PD-L1 Biomarker Testing Market Share by Application (2017-2028) Figure 28. North America PD-L1 Biomarker Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 29. U.S. PD-L1 Biomarker Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. Canada PD-L1 Biomarker Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. Europe PD-L1 Biomarker Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 32. Germany PD-L1 Biomarker Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. France PD-L1 Biomarker Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. U.K. PD-L1 Biomarker Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. Italy PD-L1 Biomarker Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Russia PD-L1 Biomarker Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. Asia-Pacific PD-L1 Biomarker Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 38. China PD-L1 Biomarker Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Japan PD-L1 Biomarker Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. South Korea PD-L1 Biomarker Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. India PD-L1 Biomarker Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Australia PD-L1 Biomarker Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Taiwan PD-L1 Biomarker Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Indonesia PD-L1 Biomarker Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Thailand PD-L1 Biomarker Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Malaysia PD-L1 Biomarker Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Philippines PD-L1 Biomarker Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Latin America PD-L1 Biomarker Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 49. Mexico PD-L1 Biomarker Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Brazil PD-L1 Biomarker Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Argentina PD-L1 Biomarker Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Middle East & Africa PD-L1 Biomarker Testing Market Size Growth Rate 2017-2028 (US$ Million) Figure 53. Turkey PD-L1 Biomarker Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. Saudi Arabia PD-L1 Biomarker Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 55. UAE PD-L1 Biomarker Testing Market Size Growth Rate (2017-2028) & (US$ Million) Figure 56. Agilent Technologies Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022) Figure 57. Roche Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022) Figure 58. Merck Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022) Figure 59. Bristol-Myers Squibb Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022) Figure 60. AstraZeneca Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022) Figure 61. Ono Pharmaceutical Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022) Figure 62. Regeneron Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022) Figure 63. Innovent Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022) Figure 64. Hengrui Medicine Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022) Figure 65. Junshi Biosciences Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

Agilent Technologies Roche Merck Bristol-Myers Squibb AstraZeneca Ono Pharmaceutical Regeneron Innovent Hengrui Medicine Junshi Biosciences